MARROW CYTOMETRY AND PROGNOSIS IN MYELOMA

被引：53

作者：

BARLOGIE, B

ALEXANIAN, R

GEHAN, EA

SMALLWOOD, L

SMITH, T

DREWINKO, B

机构：

[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT MED,HOUSTON,TX 77030

[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT BIOMATH,HOUSTON,TX 77030

[3] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT LAB MED,HOUSTON,TX 77030

来源：

关键词：

D O I：

10.1172/JCI111056

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：853 / 861

页数：9

共 26 条

[1]

ALEXANIAN R, 1980, BLOOD, V56, P521

[2]

ALEXANIAN R, 1975, CANCER, V36, P1192, DOI 10.1002/1097-0142(197510)36:4<1192::AID-CNCR2820360403>3.0.CO

[3]

2-I

[4]

ALEXANIAN R, 1981, CANCER, V47, P1923, DOI 10.1002/1097-0142(19810415)47:8<1923::AID-CNCR2820470802>3.0.CO

[5]

2-Z

[6]

ALEXANIAN R, 1983, BLOOD

[7]

BARLOGIE B, 1980, BLOOD CELLS, V6, P719

[8]

BARLOGIE B, 1976, BLOOD, V48, P245

[9]

BARLOGIE B, 1982, CLIN HEMATOLOGY, P19

[10]

BATAILLE R, 1982, CLIN HAEMATOLOGY, P113